3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, Eosinophilic, Acute
1
Leukemia, Basophilic, Acute
1
Leukemia
1
Immunoglobulin Light-chain Amyloidosis
1
Congenital Abnormalities
1
Interventions
Cyclophosphamide
27
Rituximab
20
Etoposide
14
Cytarabine
13
Melphalan
11
Vincristine
10
fludarabine
9
Prednisone
9
Doxorubicin
9
Busulfan
8
Peripheral Blood Stem Cell Transplantation
7
Radiotherapy
6
Filgrastim
6
Cyclosporine
6
Bendamustine Hydrochloride
6
fludarabine phosphate
5
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
5
Mycophenolic Acid
5
Cisplatin
5
tositumomab I-131
4
ibritumomab tiuxetan
4
Ifosfamide
4
Dexamethasone
4
Carmustine
4
relmacabtagene autoleucel
3
Thiotepa
3
Indium
3
Immunotherapy, Adoptive
3
Gemcitabine
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, Non-Hodgkin
×
dexamethasone acetate
×
Clear all
NCT01653067
2016-10-27
STORM
University Hospital Heidelberg
Phase 2
Unknown
88 enrolled